BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 26923525)

  • 1. The prevalence and clinical characteristics of hypersexuality in patients with Parkinson's disease following dopaminergic therapy: A systematic literature review.
    Nakum S; Cavanna AE
    Parkinsonism Relat Disord; 2016 Apr; 25():10-6. PubMed ID: 26923525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypersexuality and other impulse control disorders in Parkinson's disease].
    Nelis EA; Berendse HW; van den Heuvel OA
    Ned Tijdschr Geneeskd; 2016; 160():A9359. PubMed ID: 26732226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impulse control disorders in Parkinson's disease.
    Marques A; Durif F; Fernagut PO
    J Neural Transm (Vienna); 2018 Aug; 125(8):1299-1312. PubMed ID: 29511827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson's disease.
    Politis M; Loane C; Wu K; O'Sullivan SS; Woodhead Z; Kiferle L; Lawrence AD; Lees AJ; Piccini P
    Brain; 2013 Feb; 136(Pt 2):400-11. PubMed ID: 23378222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.
    Girard R; Obeso I; Thobois S; Park SA; Vidal T; Favre E; Ulla M; Broussolle E; Krack P; Durif F; Dreher JC
    Brain; 2019 Jan; 142(1):146-162. PubMed ID: 30590514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impulsive-compulsive syndrome in Parkinson's disease].
    Nikitina AV; Fedorova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
    Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
    Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypomania and mania related to dopamine replacement therapy in Parkinson's disease.
    Maier F; Merkl J; Ellereit AL; Lewis CJ; Eggers C; Pedrosa DJ; Kalbe E; Kuhn J; Meyer TD; Zurowski M; Timmermann L
    Parkinsonism Relat Disord; 2014 Apr; 20(4):421-7. PubMed ID: 24467817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypersexuality in Parkinson's disease. Advantage of the presence of the entourage for medical assessment].
    Grandgenevre P; Warembourg F; Carrière N; Vaillant A; Defebvre L; Vaiva G
    Presse Med; 2015 Mar; 44(3):e51-8. PubMed ID: 25578547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease-related disorders in the impulsive-compulsive spectrum.
    Wolters ECh; van der Werf YD; van den Heuvel OA
    J Neurol; 2008 Sep; 255 Suppl 5():48-56. PubMed ID: 18787882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex, drugs and Parkinson's disease.
    Ushe M; Perlmutter JS
    Brain; 2013 Feb; 136(Pt 2):371-3. PubMed ID: 23413258
    [No Abstract]   [Full Text] [Related]  

  • 12. Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list.
    Fusaroli M; Raschi E; Contin M; Sambati L; Menchetti M; Fioritti A; Poluzzi E
    Parkinsonism Relat Disord; 2021 Sep; 90():79-83. PubMed ID: 34399162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study.
    Vela L; Martínez Castrillo JC; García Ruiz P; Gasca-Salas C; Macías Macías Y; Pérez Fernández E; Ybot I; Lopez Valdés E; Kurtis MM; Posada Rodriguez IJ; Mata M; Ruiz Huete C; Eimil M; Borrue C; Del Val J; López-Manzanares L; Rojo Sebastian A; Marasescu R
    J Neurol Sci; 2016 Sep; 368():150-4. PubMed ID: 27538621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease].
    Sáez-Francàs N; Martí Andrés G; Ramírez N; de Fàbregues O; Álvarez-Sabín J; Casas M; Hernández-Vara J
    Neurologia; 2016 May; 31(4):231-8. PubMed ID: 26096669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impulsive and compulsive behaviors in Parkinson's disease.
    Evans AH; Strafella AP; Weintraub D; Stacy M
    Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.
    Auyeung M; Tsoi TH; Tang WK; Cheung CM; Lee CN; Li R; Yeung E
    Parkinsonism Relat Disord; 2011 Sep; 17(8):635-7. PubMed ID: 21705258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compulsive behaviors in patients with Parkinson's disease.
    Kenangil G; Ozekmekçi S; Sohtaoglu M; Erginöz E
    Neurologist; 2010 May; 16(3):192-5. PubMed ID: 20445429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
    Klos KJ; Bower JH; Josephs KA; Matsumoto JY; Ahlskog JE
    Parkinsonism Relat Disord; 2005 Sep; 11(6):381-6. PubMed ID: 16109498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
    Seeman P
    Synapse; 2015 Apr; 69(4):183-9. PubMed ID: 25645960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.